These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26299854)

  • 1. [Glucokinase and glucokinase regulatory proteins as molecular targets for novel antidiabetic drugs].
    Rubtsov PM; Igudin EL; Tiulpakov AN
    Mol Biol (Mosk); 2015; 49(4):555-60. PubMed ID: 26299854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Updates on Glucokinase Activators and Glucokinase Regulatory Protein Disrupters for the Treatment of Type 2 Diabetes Mellitus.
    Kaushik A; Kaushik M
    Curr Diabetes Rev; 2019; 15(3):205-212. PubMed ID: 30039763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors.
    Lloyd DJ; St Jean DJ; Kurzeja RJ; Wahl RC; Michelsen K; Cupples R; Chen M; Wu J; Sivits G; Helmering J; Komorowski R; Ashton KS; Pennington LD; Fotsch C; Vazir M; Chen K; Chmait S; Zhang J; Liu L; Norman MH; Andrews KL; Bartberger MD; Van G; Galbreath EJ; Vonderfecht SL; Wang M; Jordan SR; Véniant MM; Hale C
    Nature; 2013 Dec; 504(7480):437-40. PubMed ID: 24226772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Small-Molecule Glucokinase Regulatory Protein Modulators That Restore Glucokinase Activity.
    Chen K; Michelsen K; Kurzeja RJ; Han J; Vazir M; St Jean DJ; Hale C; Wahl RC
    J Biomol Screen; 2014 Aug; 19(7):1014-23. PubMed ID: 24717911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of hepatocyte glucose metabolism by novel small molecule glucokinase activators.
    Brocklehurst KJ; Payne VA; Davies RA; Carroll D; Vertigan HL; Wightman HJ; Aiston S; Waddell ID; Leighton B; Coghlan MP; Agius L
    Diabetes; 2004 Mar; 53(3):535-41. PubMed ID: 14988235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A patent review of glucokinase activators and disruptors of the glucokinase--glucokinase regulatory protein interaction: 2011-2014.
    Filipski KJ; Pfefferkorn JA
    Expert Opin Ther Pat; 2014 Aug; 24(8):875-91. PubMed ID: 24821087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular targeting of the GK-GKRP pathway in diabetes.
    Hale C; Lloyd DJ; Pellacani A; Véniant MM
    Expert Opin Ther Targets; 2015 Jan; 19(1):129-39. PubMed ID: 25324018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: a sequestration mechanism in metabolic regulation.
    Farrelly D; Brown KS; Tieman A; Ren J; Lira SA; Hagan D; Gregg R; Mookhtiar KA; Hariharan N
    Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14511-6. PubMed ID: 10588736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Developments in Medicinal Chemistry of Allosteric Activators of Human Glucokinase for Type 2 Diabetes Mellitus Therapeutics.
    Grewal AS; Lather V; Charaya N; Sharma N; Singh S; Kairys V
    Curr Pharm Des; 2020; 26(21):2510-2552. PubMed ID: 32286938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An allosteric activator of glucokinase impairs the interaction of glucokinase and glucokinase regulatory protein and regulates glucose metabolism.
    Futamura M; Hosaka H; Kadotani A; Shimazaki H; Sasaki K; Ohyama S; Nishimura T; Eiki J; Nagata Y
    J Biol Chem; 2006 Dec; 281(49):37668-74. PubMed ID: 17028192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of glucokinase by glucose, small-molecule activator and glucokinase regulatory protein: steady-state kinetic and cell-based analysis.
    Bourbonais FJ; Chen J; Huang C; Zhang Y; Pfefferkorn JA; Landro JA
    Biochem J; 2012 Feb; 441(3):881-7. PubMed ID: 22044397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis for the role of glucokinase regulatory protein as the allosteric switch for glucokinase.
    Choi JM; Seo MH; Kyeong HH; Kim E; Kim HS
    Proc Natl Acad Sci U S A; 2013 Jun; 110(25):10171-6. PubMed ID: 23733961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylation of glucokinase regulatory protein decreases glucose metabolism by suppressing glucokinase activity.
    Park JM; Kim TH; Jo SH; Kim MY; Ahn YH
    Sci Rep; 2015 Dec; 5():17395. PubMed ID: 26620281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent updates on glucokinase activators for the treatment of type 2 diabetes mellitus.
    Grewal AS; Sekhon BS; Lather V
    Mini Rev Med Chem; 2014; 14(7):585-602. PubMed ID: 25052034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects.
    Matschinsky FM; Zelent B; Doliba NM; Kaestner KH; Vanderkooi JM; Grimsby J; Berthel SJ; Sarabu R
    Handb Exp Pharmacol; 2011; (203):357-401. PubMed ID: 21484579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus.
    Xu J; Lin S; Myers RW; Addona G; Berger JP; Campbell B; Chen HS; Chen Z; Eiermann GJ; Elowe NH; Farrer BT; Feng W; Fu Q; Kats-Kagan R; Kavana M; Malkani S; McMasters DR; Mitra K; Pachanski MJ; Tong X; Trujillo ME; Xu L; Zhang B; Zhang F; Zhang R; Parmee ER
    Bioorg Med Chem Lett; 2017 May; 27(9):2069-2073. PubMed ID: 28284804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of glucokinase regulatory protein expression may contribute to low glucokinase activity in feline liver.
    Hiskett EK; Suwitheechon OU; Lindbloom-Hawley S; Boyle DL; Schermerhorn T
    Vet Res Commun; 2009 Mar; 33(3):227-40. PubMed ID: 18780155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of type 2 diabetes by adenoviral-mediated overexpression of the glucokinase regulatory protein.
    Slosberg ED; Desai UJ; Fanelli B; St Denny I; Connelly S; Kaleko M; Boettcher BR; Caplan SL
    Diabetes; 2001 Aug; 50(8):1813-20. PubMed ID: 11473043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of allosteric activation and inhibition of glucokinase.
    Zelent B; Odili S; Buettger C; Zelent DK; Chen P; Fenner D; Bass J; Stanley C; Laberge M; Vanderkooi JM; Sarabu R; Grimsby J; Matschinsky FM
    Biochem J; 2011 Dec; 440(2):203-15. PubMed ID: 21831042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetrahydropalmatine from medicinal plants activates human glucokinase to regulate glucose homeostasis.
    Singh S; Ghosh P; Sharma S; Bhargava S; Kumar AR
    Biotechnol Appl Biochem; 2024 Apr; 71(2):295-313. PubMed ID: 38037220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.